内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡

2022-04-21 欧洲罕见内分泌疾病参考网 Eur J Endocrinol

先天性垂体或性腺生殖激素缺乏症

2022年4月，欧洲罕见内分泌疾病参考网(ENDO-ERN)发布了先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡指南。指南主要目的是为先天性垂体或性腺生殖激素缺乏症患者的临床评

中文标题：

2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡

英文标题：

Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline

发布机构：

欧洲罕见内分泌疾病参考网

发布日期：

2022-04-21

简要介绍：

2022年4月，欧洲罕见内分泌疾病参考网(ENDO-ERN)发布了先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡指南。指南主要目的是为先天性垂体或性腺生殖激素缺乏症患者的临床评估和青春期诱导提供实践指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡.pdf)] GetToolGuiderByIdResponse(projectId=1, id=43e4c1c002a36041, title=2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡, enTitle=Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline, guiderFrom=Eur J Endocrinol, authorId=0, author=, summary=2022年4月，欧洲罕见内分泌疾病参考网(ENDO-ERN)发布了先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡指南。指南主要目的是为先天性垂体或性腺生殖激素缺乏症患者的临床评, cover=https://img.medsci.cn/20220513/1652448109397_1608702.jpg, journalId=0, articlesId=null, associationId=2713, associationName=欧洲罕见内分泌疾病参考网, associationIntro=欧洲罕见内分泌疾病参考网(ENDO-ERN,European Reference Network on rare endocrine conditions), copyright=0, guiderPublishedTime=Thu Apr 21 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年4月，欧洲罕见内分泌疾病参考网(ENDO-ERN)发布了先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡指南。指南主要目的是为先天性垂体或性腺生殖激素缺乏症患者的临床评估和青春期诱导提供实践指导建议。</span></p>, tagList=[TagDto(tagId=437929, tagName=先天性垂体或性腺生殖激素缺乏症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2794, appHits=30, showAppHits=0, pcHits=189, showPcHits=2764, likes=1, shares=4, comments=2, approvalStatus=1, publishedTime=Sat May 14 15:19:00 CST 2022, publishedTimeString=2022-04-21, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri May 13 21:23:12 CST 2022, updatedBy=6477789, updatedName=MS南菜园, updatedTime=Fri Jan 05 22:43:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡.pdf)])
2022 Endo-ERN临床实践指南：先天性垂体或性腺生殖激素缺乏症患者青春期诱导以及向成年性激素替代的过渡.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1238941, encodeId=c99e1238941e9, content=受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45e02954503, createdName=xyjabc, createdTime=Tue Aug 16 07:07:41 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238940, encodeId=b6cf12389403b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45e02954503, createdName=xyjabc, createdTime=Tue Aug 16 07:07:31 CST 2022, time=2022-08-16, status=1, ipAttribution=)]
    2022-08-16 xyjabc

    受教了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1238941, encodeId=c99e1238941e9, content=受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45e02954503, createdName=xyjabc, createdTime=Tue Aug 16 07:07:41 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238940, encodeId=b6cf12389403b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45e02954503, createdName=xyjabc, createdTime=Tue Aug 16 07:07:31 CST 2022, time=2022-08-16, status=1, ipAttribution=)]
    2022-08-16 xyjabc

    真好

    0